“Tumor Suppressor Gene TP53 Mutated in 90 Percent of Most Common Childhood Bone Tumor,” St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center

The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project found mutations in the tumor suppressor gene TP53 in 90 percent of osteosarcomas, suggesting the alteration plays a key role early in development of the bone cancer. The research was published Thursday online ahead of print in the journal Cell Reports. Authors from this story also represent The University of Texas MD Anderson Cancer Center and Siteman Cancer Center at Barnes-Jewish Hospital and Washin...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news